And that's good.
Safe and effective vaccines by the end of this year?
The antimalarial drug is being removed from United Kingdom's RECOVERY trial evaluating COVID-19 therapies.
The observational dataset on which it was based could not be properly audited.
A major study in The Lancet said it doesn't—but it may have relied on fabricated data.
The World Health Organization pauses clinical trials in light of disturbing new results.
Volunteers would earn cash for the risks they take on our behalf.
Promising randomized controlled trial results indicate the drug shortens time to recovery
A contrast with last week's leaked results from a University of Chicago study
STAT reports leaked comments of University of Chicago researcher
"The best available evidence does not support the use of hydroxychloroquine in COVID-19."
An idea that could really speed up vaccine development
FDA is reportedly cutting red tape to give expanded access to COVID-19 patients.
Slashing the restraints on the agency's slow and burdensome process.
"Right to try" laws offer hope for people trying to save their own lives.